Comparative Effectiveness: The Next Gatekeeper to Commercial Success

The hot new buzzword with policymakers is comparative clinical effectiveness, and everyone has an idea on how to make it work. But major questions remain: what might a national effort look like? And will payors use it to restrict access to new drugs?

By Kate Rawson

As policymakers search to find ways to restrain drug expenditures without using overt price controls, one proposal keeps coming up: comparative clinical effectiveness research.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D